
| ID | 16408 |
| Eprint ID | 16408
|
| フルテキストURL | |
| タイトル(別表記) | Immunochemotherapy for lung cancer I. Evaluation of the immunopotentiators OK-432 and PSK
|
| 著者 |
野田 憲男
岡山大学医学部第2内科教室
|
| 抄録 | Fifty-five patients with advanced lung cancer were divided at random into three groups. The first group of 19 patients was treated with OK-432 administered intramuscularly in addition to combination chemotherapy. The second group of 18 patients was treated with PSK in addition to combination chemotherapy. The third group of 18 patients was treated with combination chemotherapy only. There were no significant differences in age, histological type, extent of disease, Performance status or initial chemotherapy between the three treatment groups. The median survival was longer in the patients who received OK-432 (7.5 months) than that of the patients who received either PSK (7.0 months) or no immunotherapy (5.8 months), but this difference was not statistically significant. The degree of myelosuppression induced by the combination chemotherapy and the frequency of febrile episodes were less in the groups administered OK-432 and PSK. These results suggest that these immunopotentiators, especially OK-432, may be useful immunotherapeutic agents in combination with chemotherapy in advanced stages of lung cancer.
|
| キーワード | 肺癌 (lung cancer)
免疫化学療法 (immunochemotherapy)
OK-432
PSK
Randomized control study
|
| 発行日 | 1983-12-30
|
| 出版物タイトル |
岡山医学会雑誌
|
| 出版物タイトル(別表記) | Journal of Okayama Medical Association
|
| 巻 | 95巻
|
| 号 | 11-12号
|
| 出版者 | 岡山医学会
|
| 出版者(別表記) | Okayama Medical Association
|
| 開始ページ | 1137
|
| 終了ページ | 1143
|
| ISSN | 0030-1558
|
| NCID | AN00032489
|
| 資料タイプ |
学術雑誌論文
|
| オフィシャル URL | https://www.jstage.jst.go.jp/article/joma1947/95/11-12/95_11-12_1137/_article/-char/ja/
|
| 関連URL | http://www.okayama-u.ac.jp/user/oma/index.html
|
| 言語 |
日本語
|
| 著作権者 | 岡山医学会
|
| 論文のバージョン | publisher
|
| 査読 |
有り
|
| Eprints Journal Name | joma
|